Donna Neuberg
0000-0003-2566-3145
Publication & Citation Trends
Publications
0 total
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in Myeloma.
Cited by 0
Semantic Scholar
PROGNOSTIC VALUE OF CIRCULATING TUMOR DNA IN PATIENTS WITH ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA TREATED ON SWOG S1826
Cited by 4
Semantic Scholar
Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826
Cited by 0
Semantic Scholar
Pre-existing cytotoxic capacity of CD8+ and CD4+ T cells is a hallmark of richter transformation and favors response to anti-PD-1 therapy
Cited by 0
Semantic Scholar
Murine modeling of cluster 1 diffuse large B-cell lymphoma reveals transformation from marginal zone lymphoma
Cited by 0
Semantic Scholar
Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia
Cited by 12
Semantic Scholar
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway
Cited by 1
Semantic Scholar
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Cited by 1
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(382)
Acute Myeloid Leukemia Research
(325)
Acute Lymphoblastic Leukemia research
(293)
Lymphoma Diagnosis and Treatment
(264)
Cancer Genomics and Diagnostics
(171)
Affiliations
Broad Institute
Boston University
Northwestern University
Otsuka (Japan)
University of Southern California